Michael A. Pucker Telecopy Uses in Notices Clause

Notices from Amended and Restated Registration Rights Agreement

THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this Agreement), dated as of September 25, 2003, is by and among RELIANT PHARMACEUTICALS, LLC, a Delaware limited liability company (the Company), and the members of the Company listed on Exhibit A hereto (the Members). For the purposes of this Agreement, the term Company shall be deemed to include and refer to any successor in interest to the Company, whether by means of statutory conversion, merger, consolidation or otherwise.

Notices. Any notices required or permitted to be sent hereunder shall be delivered personally, via facsimile transmission (with confirmation), or mailed, via certified mail (return receipt requested), or delivered by overnight courier service to the following addresses, or such other address as any party hereto designates by written notice to the Company, and shall be deemed to have been given upon delivery, if delivered personally or via facsimile, three (3) Business Days after mailing, if mailed, or one (1) Business Day after delivery to the courier, if delivered by overnight courier service: if to the Company to: Reliant Pharmaceuticals, LLC 110 Allen Road Liberty Corner, New Jersey 07938 Attention: Chief Executive Officer Telecopy: (908) 542-9405 with copies sent concurrently to: Reliant Pharmaceuticals, LLC 110 Allen Road Liberty Corner, New Jersey 07938 Attention: General Counsel Telecopy: (908) 542-9405 Latham & Watkins LLP 5800 Sears Tower 233 South Wacker Drive Chicago, Illinois 60606 Attention: Michael A. Pucker Telecopy: (312) 993-9767 if to any holder of Registrable Securities: to the address of such holder as the same appears on the signature page hereto (with copies to any parties identified thereon) or, otherwise on the books and

Notices from Amended and Restated Registration Rights Agreement

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this Agreement), dated as of June 5, 2007, is made and entered into by and among VIA PHARMACEUTICALS, INC., a Delaware corporation (the Company), and each of the stockholders of the Company listed on Exhibit A hereto, as such Exhibit A may be amended from time to time (the Stockholders). For the purposes of this Agreement, the term Company shall be deemed to include and refer to any successor in interest to the Company, whether by means of statutory conversion, merger, consolidation, recapitalization, reorganization or otherwise.

Notices. Any notices required or permitted to be sent hereunder shall be delivered personally, via facsimile transmission (with confirmation), or mailed, via certified mail (return receipt requested), or delivered by overnight courier service to the following addresses, or such other address as any party hereto designates by written notice to the Company, and shall be deemed to have been given upon delivery, if delivered personally or via facsimile, three (3) Business Days after mailing, if mailed, or one (1) Business Day after delivery to the courier, if delivered by overnight courier service: if to the Company to: VIA Pharmaceuticals, Inc. 750 Battery Street, Suite 330 San Francisco, California 94111 Attention: Chief Executive Officer Telecopy: (415) 283-2201 with copies sent concurrently to: Latham & Watkins LLP 5800 Sears Tower 233 South Wacker Drive Chicago, Illinois 60606 Attention: Michael A. Pucker Telecopy: (312) 993-9767 if to any holder of Registrable Securities: to the address of such holder as the same appears on Exhibit A hereto (with copies to any parties identified thereon) or, otherwise on the books and records of the Company.

Notices from Change of Control Agreement

THIS CHANGE OF CONTROL AGREEMENT (Agreement) dated as of March 19, 2002 is entered by and between Stefan Aigner (Executive) and Reliant Pharmaceuticals, LLC, a Delaware limited liability company (the Company).

Notices. Any notices required or permitted to be sent hereunder shall be delivered personally, via facsimile transmission (with confirmation), or mailed, via certified mail (return receipt requested), or delivered by overnight courier service to the following addresses, or such other address as any party hereto designates by written notice to the Company, and shall be deemed to have been given upon delivery, if delivered personally or via facsimile, three (3) business days after mailing, if mailed, or one (1) business day after delivery to the courier, if delivered by overnight courier service: if to the Company to: Reliant Pharmaceuticals, LLC 110 Allen Road Liberty Corner, New Jersey 07938 Attention: President Telecopy: (908) 542-9406 with copies sent concurrently to: Reliant Pharmaceuticals, LLC 110 Allen Road Liberty Corner, New Jersey 07938 Attention: General Counsel Telecopy: (908) 542-9406 Latham & Watkins Sears Tower, Suite 5800 233 South Wacker Drive Chicago, Illinois 60606 Attention: Michael A. Pucker Telecopy: (312) 993-9767 If to Executive, to him at his most recent address as reflected in the Companys records. Either party may change its address for notice under this Section 13(e) upon written notice to the other party, such notice to be effective upon receipt.

Notices from Amended and Restated Registration Rights Agreement

THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this Agreement), dated as of September 25, 2003, is by and among RELIANT PHARMACEUTICALS, LLC, a Delaware limited liability company (the Company), and the members of the Company listed on Exhibit A hereto (the Members). For the purposes of this Agreement, the term Company shall be deemed to include and refer to any successor in interest to the Company, whether by means of statutory conversion, merger, consolidation or otherwise.

Notices. Any notices required or permitted to be sent hereunder shall be delivered personally, via facsimile transmission (with confirmation), or mailed, via certified mail (return receipt requested), or delivered by overnight courier service to the following addresses, or such other address as any party hereto designates by written notice to the Company, and shall be deemed to have been given upon delivery, if delivered personally or via facsimile, three (3) Business Days after mailing, if mailed, or one (1) Business Day after delivery to the courier, if delivered by overnight courier service: if to the Company to: Reliant Pharmaceuticals, LLC 110 Allen Road Liberty Corner, New Jersey 07938 Attention: Chief Executive Officer Telecopy: (908) 542-9405 with copies sent concurrently to: Reliant Pharmaceuticals, LLC 110 Allen Road Liberty Corner, New Jersey 07938 Attention: General Counsel Telecopy: (908) 542-9405 Latham & Watkins LLP 5800 Sears Tower 233 South Wacker Drive Chicago, Illinois 60606 Attention: Michael A. Pucker Telecopy: (312) 993-9767 if to any holder of Registrable Securities: to the address of such holder as the same appears on the signature page hereto (with copies to any parties identified thereon) or, otherwise on the books and records of the Company1. 1 Any notices given hereunder to Alkermes, Inc. shall also be copied to Ballard Spahr Andrews & Ingersoll, LLP, 1735 Market Street, 51st floor, Philadelphia, Pennsylvania 19103, (facsimile: 215/864-8999); Attention: Morris Cheston, Jr.